来宝网Logo

热门词:生物显微镜 水质分析仪 微波消解 荧光定量PCR 电化学工作站 生物安全柜

现在位置首页>技术资料首页>行业动态>新品动态>HealthLinx OvPlex 将在印度销售

HealthLinx OvPlex 将在印度销售

HealthLinx2012年5月21日 10:32 点击:1461


澳大利亚HealthLinx
 

HealthLinx  OvPlex 将在印度销售

15 May 2012

HealthLinx Limited with distribution partners INEX Innovations Exchange and Metropolis Healthcare will begin selling OvPlex, a diagnostic test that helps to detect ovarian cancer, in India, beginning the third quarter of 2012

ovplex-winner-of-biospectrum-asia-pacific-bioscience-industry-product-of-the-year-award-for-2010-will-be-sold-in-india-from-q3-2012

OvPlex-winner of BioSpectrum Asia Pacific Bioscience Industry Product of the Year Award for 2010- will be sold in India from Q3 2012

Related Articles

 

Mumbai: HealthLinx Limited with distribution partners INEX Innovations Exchange and Metropolis Healthcare will begin selling OvPlex in India beginning the third quarter of 2012. OvPlex will be available in Mumbai from August 1, 2012, with extension of distribution to take place through all major Indian cities over the following six months.

OvPlex is a diagnostic test that measures levels of five proteins in a patient's blood. One of the proteins is CA125, which has been used for several years for the detection and monitoring of ovarian cancer. When measured along with the four additional proteins that make up OvPlex, a significant enhancement in diagnostic performance can be achieved. In recognition of its ability to address unmet medical needs, OvPlex won the BioSpectrum Asia Pacific Bioscience Industry Product of the Year Award for 2010.

Metropolis Healthcare was founded by Dr Sushil Shah in 1981. Metropolis Healthcare is India's leading multinational chain of 85 diagnostic centers and 600 collection centres across India, Sri Lanka, South Africa and Middle East.

This rapid expansion of jurisdictions in Asia, in which OvPlex is available, is prompted by excellent market acceptance and growth in Singapore and Malaysia, where it has been on the market since October 2010. Since this time, INEX has exceeded expected sales targets by approximately 25 percent and continues to grow.

HealthLinx and its partners INEX and Metropolis Healthcare expect sales in India to grow rapidly over the next six months. Healthlinx and INEX are also exploring the opportunity of obtaining private insurance reimbursement on the test, and that should further increase sales.

"This expansion is an excellent result for women in India who will shortly have access to OvPlex" said Mr Nick Gatsios, managing director. "As a company we are excited with INEX's proactive expansion strategies and management of both companies is working very closely to ensure further expansion occurs in a seamless, cohesive and timely manner."

Plans to expand into other jurisdictions, to which INEX has an option in their distribution agreement, including Indonesia and Thailand, will be announced in shortly.

(来源: HealthLinx )


全年征稿 / 资讯合作

联系邮箱:kefu@labbase.net

版权与免责声明

  • 凡本网注明“来源:来宝网”的所有作品,版权均属于来宝网,转载请必须注明来宝网, http://www.labbase.net,违反者本网将追究相关法律责任。
  • 本网转载并注明自其它来源的作品,目的在于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时,必须保留本网注明的作品来源,并自负版权等法律责任。
  • 如涉及作品内容、版权等问题,请在作品发表之日起一周内与本网联系,否则视为放弃相关权利。